McLean Hospital

Running trials

• Not yet recruiting

  Pilot Study of Sensor-Informed Smartphone-based Mental Health Interventions for Mood in Early Psychosis

  NCT07503093· Source

• Recruiting

  Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101

  NCT07785102· Early phase 1· Source

• Recruiting

  Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder

  NCT07593222· Phase 1/2· Source

• Recruiting

  One-Day cTBS Over the Precuneus

  NCT07758010· Source

• Recruiting

  Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain

  NCT07728695· Phase 1/2· Source

• Recruiting

  Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression

  NCT07560878· Early phase 1· Source

• Recruiting

  A Study of Brenipatide in Adult Participants With Schizophrenia

  NCT07410507· Phase 2· Source

• Recruiting

  Stress Dynamics and Familial Risk for Depression in Female Adolescents

  NCT06816329· Source

• Recruiting

  Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans

  NCT06105164· Source

• Active, not recruiting

  Sequential Multiple Assignment Randomized Trial for Bipolar Depression

  NCT06433635· Phase 4· Source

• Recruiting

  A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  NCT06585787· Phase 3· Source

• Enrolling by invitation

  Open Label Extension Study of NCT06221852

  NCT06558201· Source

• Recruiting

  Cerebellar Modulation of Cognition in Psychosis

  NCT06107764· Source

• Recruiting

  MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction

  NCT06191965· Phase 2/3· Source

• Recruiting

  Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder

  NCT06221852· Source

• Active, not recruiting

  Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis

  NCT06477406· Phase 2· Source

• Recruiting

  Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder

  NCT06373016· Source

• Recruiting

  Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder

  NCT05837104· Phase 2· Source

• Recruiting

  Cerebellar TMS and Satiety in Prader-Willi Syndrome

  NCT05938543· Source

• Recruiting

  Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder

  NCT05457465· Phase 2· Source

• Active, not recruiting

  Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

  NCT05711940· Phase 3· Source

• Recruiting

  Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

  NCT06740383· Source

• Recruiting

  Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

  NCT05245903· Source

• Recruiting

  Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression

  NCT05630963· Source

• Recruiting

  Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia

  NCT05343598· Source

• Recruiting

  Neural Correlates of Stress and Perceived Control in Adolescent Depression

  NCT04788524· Source

• Active, not recruiting

  Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.2 (Stress Manipulation)

  NCT04325529· Source

• Active, not recruiting

  Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia

  NCT04075435· Early phase 1· Source

• Active, not recruiting

  A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

  NCT03887455· Phase 3· Source

• Active, not recruiting

  ERG Components in Schizophrenia and Bipolar Disorder Type I

  NCT03788811· Source

• Active, not recruiting

  Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression

  NCT03484494· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Schizophrenia9 recruiting
• Depression8 recruiting
• Bipolar disorder7 recruiting
• Alzheimer disease2 recruiting
• Endometriosis1 recruiting
• Obesity1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care

  NCT07364825· Source

• Completed

  PRISM Neurofeedback Training for MDD Anhedonic Patients

  NCT05869708· Source

• Completed

  SMART Trial to Predict Anhedonia Response to Antidepressant Treatment

  NCT05537584· Phase 4· Source

• Terminated

  A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

  NCT05310071· Phase 3· Source

• Completed

  Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot Study

  NCT05380583· Source

• Completed

  Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia

  NCT04430517· Early phase 1· Source

• Completed

  Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)

  NCT03926520· Source

• Completed

  Behavioral and Electrophysiological Effects of Ketamine in Treatment-Resistant Depression

  NCT04239963· Source

• Terminated

  A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205

  NCT04241068· Phase 3· Source

• Completed

  Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders

  NCT03943537· Phase 2· Source

• Completed

  Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease

  NCT02792257· Phase 2· Source

Trial sites

• Harvard Medical School - McLean Hospital1 trial
• McLean Hospital41 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Schizophrenia71 works · 13 trials
• Depression52 works · 13 trials
• Bipolar disorder39 works · 12 trials